News & Media

Press Releases

Amolyt Pharma Exercises Option to License Optimized Acromegaly Drug Candidate from PeptiDream as it Continues to Build its Rare Endocrine Pipeline

September 9, 2021

Download a PDF copy of this press release: EN FR Company to develop AZP-3813 as a potential treatment for acromegaly following successful research collaboration between …

Download a PDF: EN or FR

Amolyt Pharma Announces Appointment of Two Directors

July 8, 2021

Download a PDF copy of this press release: EN FR Elisabeth Svanberg, M.D., Ph.D. brings extensive experience in the development of therapeutics for under-served endocrine, …

Download a PDF: EN or FR

Amolyt Pharma Announces Hiring of Louis J. Arcudi III as Chief Financial Officer

July 6, 2021

Download a PDF copy of this press release: EN FR Appointment of US-based CFO adds more than 20 years of biotechnology financial, strategic, and operational …

Download a PDF: EN or FR

Presentations

AZP-3404

Improved Glucose Metabolism and Decreased Weight Gain in Leptin-Resistant, IGFBP2-Deficient, db/db Mice Induced by AZP-3404, a 9-Amino Acid Analog of IGFBP2. e-ECE 2021.

Written by

jpoly4

AZP-3601

Safety, Tolerability and Pharmacodynamics of AZP-3601, a Novel Long-Acting PTH Analog, in Healthy Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. e-ECE 2021.

Written by

jpoly4

AZP-3601

cHP Natural History Study: ISPOR Poster

Written by

jpoly4

AZP-3404

AZP-3404, a Peptide Analog of IGFBP-2, Induces Weight Loss and Improves Glucose Metabolism in Leptin-Resistant db/db Mice. ENDO 2021.

Written by

jpoly4

AZP-3601

A Single Administration of AZP-3601, a Novel, Long-Acting PTH Analog, Induces a Significant and Sustained Calcemic Response: Preliminary Data From a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. ENDO 2021.

Written by

jpoly4

AZP-3601

Clinical Burden and Practice Patterns in Patients With Chronic Hypoparathyroidism in the United States (US): A Claims Data Analysis Using Diagnosis Based Criteria. ENDO 2021.

Written by

jpoly4

AZP-3601

Clinical Burden and Practice Patterns in Patients With Chronic Hypoparathyroidism in the United States (US): A Claims Data Analysis Using Surgery Based Criteria. ENDO 2021.

Written by

jpoly4

Upcoming events

90th Annual Meeting of the American Thyroid Association^®

Date: September 29 – October 3, 2021 (Virtual)

Learn more about the conference »

Hypopara Patient Association Meeting

Date: October 2021

ASBMR 2021 Annual Meeting

Date: October 1-4, 2021 (Toronto)

Learn more about the conference »

37eme Congrès de la Société Française d’Endocrinologie (SFE)

Date: October 13-16, 2021 (Le Havre)

Learn more about the conference »

AMCP Nexus 2021

Date: October 19-22, 2021 (Denver, CO)

Learn more about the conference »

American Society of Nephrology (ASN) Kidney Week 2021

Date: November 2-7, 2021 (San Diego, CA)

Learn more about the conference »

Acromegaly Awareness Day

Date: November 1, 2021